Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
基本信息
- 批准号:8525515
- 负责人:
- 金额:$ 5.19万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-06-30 至 2015-06-29
- 项目状态:已结题
- 来源:
- 关键词:Acute Erythroblastic LeukemiaAffinity ChromatographyAnemiaAnimal ModelBiologyCarrier ProteinsCell Culture TechniquesCellsChildComplexDataDefectDevelopmentDiseaseDrug Metabolic DetoxicationEnvironmentEnzymesErythrocytesErythroidErythroid CellsErythropoiesisFoundationsGenesGeneticGoalsHealthHematological DiseaseHematopoiesisHematopoieticHemeHeme IronHemoglobinHumanIronLabelLightMammalian CellMass Spectrum AnalysisMediatingMentorsMetabolic PathwayMetabolismMitochondriaMitochondrial ProteinsMusOrganOxidation-ReductionOxygenPathway interactionsPatientsPhenotypePlayPorphyriasPorphyrinsProcessProductionPronormoblastsProsthesisProteinsPublic HealthReactionRegulationResearchResearch InfrastructureRespirationRoleStagingTechniquesTestingThin Layer ChromatographyTrainingUroporphyrinogen IIIVertebratesWomanWorkZebrafishcoproporphyrinogen IIIdeuteroporphyrin-IXembryonic stem cellerythroid differentiationiron metabolismnoveloxygen transportporphyrin metabolismprogramsprotoporphyrin IXpublic health relevancesmall hairpin RNAsuccesstooltrafficking
项目摘要
DESCRIPTION (provided by applicant): The long-term goal of this project is to identify and characterize novel proteins that regulate mitochondrial heme metabolism, particularly proteins that play a role in mitochondrial heme/porphyrin transport. This project has implications for identifying genetic modifiers for erythroid porphyria and anemia, and thus has public health significance. Our lab has identified Tmem14c as a novel mitochondrial protein that is required for terminal erythroid differentiation and hemoglobinization in vertebrates. Heme synthesis enzymes are present in Tmem14c-deficient murine erythroleukemia (MEL) cells, and preliminary data from our lab indicate that iron transport in Tmem14c-deficient MEL cells is comparable to wild-type MEL cells. However, Tmem14c-deficient MEL cells synthesize decreased levels of heme and protoporphyrin IX. These data suggest that Tmem14c may facilitate mitochondrial porphyrin transport, thereby playing a key role in heme/porphyrin metabolism. In Aim 1, we will test this hypothesis by identifying the block in porphyrin metabolism in Tmem14c deficient cells, comparing the levels of uroporphyrinogen III (cytoplasmic), coproporphyrinogen III (mitochondrial/cytoplasmic) and protoporphyrin IX (mitochondrial) in the mitochondrial and cytoplasmic fractions of wild-type and Tmem14c-deficient MEL cells. In this manner, we will determine if the block in heme synthesis in Tmem14c-deficient cells is a result of defective porphyrin trafficking. As Tmem14c forms higher-order complexes with other proteins, we hypothesize that Tmem14c's interactions with its partners play a crucial role in regulating its function. In Aim 2, we will identify Tmem14c partner and characterize their role in regulating Tmem14c in the heme synthetic pathway; we will identify interacting proteins that are required for terminal erythroid differentiation, heme synthesis and porphyrin transport, and focus on characterizing proteins that regulate Tmem14c's localization and protein stability. Collectively, our studies will contribute to our lon-term objective of understanding regulatory mechanisms controlling heme metabolism, and the interaction of heme metabolism with erythropoiesis. The specific aims in this proposal are of particular significance because studies of Tmem14c function will shed light on the poorly understood porphyrin trafficking pathways that are central to the regulation of heme metabolism and erythropoiesis. These experimental aims are a logical continuation of my graduate work in hematopoiesis, but provide a framework with which to obtain substantial training in the use of the zebrafish as an animal model and additional techniques that will prove invaluable for further studies in erythroid biology.
描述(由申请人提供):该项目的长期目标是识别和表征调节线粒体血红素代谢的新型蛋白质,尤其是在线粒体血红素/卟啉传输中起作用的蛋白质。该项目对确定红斑和贫血的遗传修饰剂具有影响,因此具有公共卫生的意义。我们的实验室已将TMEM14C鉴定为一种新型的线粒体蛋白,这是脊椎动物中末端红细胞分化和血红蛋白化所必需的。血红素合成酶存在于TMEM14C缺乏的鼠红血症(MEL)细胞中,我们实验室的初步数据表明,TMEM14C缺陷的MEL细胞中的铁转运与野生型MEL细胞相当。 但是,TMEM14C缺陷型MEL细胞合成降低血红素和原核IX水平。这些数据表明TMEM14C可能促进线粒体卟啉的转运,从而在血红素/卟啉代谢中起关键作用。在AIM 1中,我们将通过鉴定TMEM14C缺陷细胞中卟啉代谢的阻滞来检验这一假设,并比较尿中核蛋白原III III(细胞质)的水平,核核原III III(cocodrial/cintoplial/cintoplasmic)和原质核酸核酸磷酸核酸磷酸酯和菌粒粒粒粒粒粒粒粒粒粒粒粒粒粒粒细胞膜和菌丝体。野生型和TMEM14C缺陷的MEL细胞的馏分。以这种方式,我们将确定TMEM14C缺陷型细胞中血红素合成的块是否是卟啉运输缺陷的结果。 由于TMEM14C与其他蛋白质形成高阶复合物,我们假设TMEM14C与其伴侣的相互作用在调节其功能方面起着至关重要的作用。在AIM 2中,我们将确定TMEM14C伴侣并表征它们在调节血红素合成途径中TMEM14C中的作用。我们将确定末端红细胞分化,血红素合成和卟啉转运所需的相互作用蛋白质,并专注于表征调节TMEM14C定位和蛋白质稳定性的蛋白质。 总的来说,我们的研究将有助于我们理解控制血红素代谢的调节机制,以及血红素代谢与促红细胞生成的相互作用。该提案中的具体目的特别重要,因为对TMEM14C功能的研究将揭示出对调节血红素代谢和红细胞生成的核心的知识较低的卟啉运输途径。这些实验目的是我在造血研究中的研究生工作的逻辑延续,但提供了一个框架,以获得斑马鱼用作动物模型的实质性培训和其他技术,这些技术对于进一步的红斑生物学研究而言是无价的。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yvette Y Yien其他文献
Yvette Y Yien的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yvette Y Yien', 18)}}的其他基金
Regulation of erythroid iron metabolism by the CLPX unfoldase
CLPX 解折叠酶对红细胞铁代谢的调节
- 批准号:
10716494 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10540604 - 财政年份:2019
- 资助金额:
$ 5.19万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10664950 - 财政年份:2019
- 资助金额:
$ 5.19万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10456295 - 财政年份:2019
- 资助金额:
$ 5.19万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10000941 - 财政年份:2019
- 资助金额:
$ 5.19万 - 项目类别:
Regulation of heme synthesis by mitochondrial proteins
线粒体蛋白对血红素合成的调节
- 批准号:
10739151 - 财政年份:2019
- 资助金额:
$ 5.19万 - 项目类别:
Mechanism and Function of TMEM14 proteins in vertebrate heme synthesis
TMEM14蛋白在脊椎动物血红素合成中的机制和功能
- 批准号:
9751281 - 财政年份:2015
- 资助金额:
$ 5.19万 - 项目类别:
Regulation of mitochondrial heme metabolism by Tmem14c
Tmem14c 对线粒体血红素代谢的调节
- 批准号:
8677578 - 财政年份:2013
- 资助金额:
$ 5.19万 - 项目类别:
Project 5 Frascati-mediated Mitochondrial Metabolism, Barry Paw
项目 5 弗拉斯卡蒂介导的线粒体代谢,Barry Paw
- 批准号:
9924635 - 财政年份:
- 资助金额:
$ 5.19万 - 项目类别:
相似国自然基金
基于亲和导向-邻近反应的复杂体系天然蛋白固定新方法及色谱评价
- 批准号:22374116
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
基于亲和色谱策略筛选和挖掘磷酸酶PP2A新型调节剂
- 批准号:22377149
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
基于仿生亲和色谱-质谱策略的肺结核患者血清抗体谱研究
- 批准号:82160027
- 批准年份:2021
- 资助金额:34 万元
- 项目类别:地区科学基金项目
基于亲和色谱靶点“钩钓”策略研究补肾活血方抗AGEs诱导神经损伤的作用机制
- 批准号:82104621
- 批准年份:2021
- 资助金额:24.00 万元
- 项目类别:青年科学基金项目
固定化单构象态受体亲和色谱的建立及止喘灵方平喘功效物质研究
- 批准号:82174088
- 批准年份:2021
- 资助金额:55.00 万元
- 项目类别:面上项目
相似海外基金
Role of neuronal hemoglobin in chronic stress-induced mitochondrial adaptation in hippocampal PV interneurons
神经元血红蛋白在海马PV中间神经元慢性应激诱导的线粒体适应中的作用
- 批准号:
10667084 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Identifying Mechanisms Involved in Hydroxyurea-Mediated Reduction in Vaso-occlusive Adhesive Events in Sickle Cell Disease
确定羟基脲介导的镰状细胞病血管闭塞性粘附事件减少机制
- 批准号:
10724590 - 财政年份:2023
- 资助金额:
$ 5.19万 - 项目类别:
Production of human mitochondrial ABC transporters for structural and biochemical studies
生产用于结构和生化研究的人类线粒体 ABC 转运蛋白
- 批准号:
10482375 - 财政年份:2021
- 资助金额:
$ 5.19万 - 项目类别:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
用于口腔鳞癌化学预防的纳米颗粒释放口腔薄膜的配方、评估和 0 期试验
- 批准号:
10540811 - 财政年份:2021
- 资助金额:
$ 5.19万 - 项目类别:
Formulation, Evaluation, and Phase 0 Trial of Nanoparticle Releasing Oral Thin Film for OSCC Chemoprevention
用于口腔鳞癌化学预防的纳米颗粒释放口腔薄膜的配方、评估和 0 期试验
- 批准号:
10359559 - 财政年份:2021
- 资助金额:
$ 5.19万 - 项目类别: